Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126643371 | 12664337 | 1 | I | 201607 | 20160725 | 20160818 | 20160818 | EXP | PE-SA-2016SA138343 | AVENTIS | 33.00 | YR | A | F | Y | 0.00000 | 20160818 | MD | PE | PE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126643371 | 12664337 | 1 | PS | THYMOGLOBULINE | LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN | 1 | Intravenous (not otherwise specified) | U | UNK | 103869 | |||||||||
| 126643371 | 12664337 | 2 | SS | ETHINYLESTRADIOL | ETHINYL ESTRADIOL | 1 | Oral | U | UNK | 0 | |||||||||
| 126643371 | 12664337 | 3 | C | CYCLOSPORIN | CYCLOSPORINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126643371 | 12664337 | 1 | Immunosuppressant drug therapy |
| 126643371 | 12664337 | 2 | Contraception |
| 126643371 | 12664337 | 3 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126643371 | 12664337 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126643371 | 12664337 | Cytomegalovirus test positive | |
| 126643371 | 12664337 | Febrile neutropenia | |
| 126643371 | 12664337 | Neutropenia | |
| 126643371 | 12664337 | Transaminases increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |